As a member benefit, MassMEDIC holds an Annual Conference in May, an Annual MedTech Investors Conference in October and a series of informational programs throughout the year on a wide range of topics of interest to MassMEDIC members, including regulatory affairs, product development trends and reimbursement issues.
MassMEDIC is pleased to team up with Right Submission and FDA Attorney Jeffrey N. Gibbs of Hyman, Phelps & McNamara, P.C. to bring you this webinar, focused on legal questions you might have relative to FDA product submissions.
Questions such as:
This is an extraordinary opportunity to get your legal questions about FDA device submissions answered. You can submit your own questions in advance of the webinar and we will pose them anonymously during the webinar. Or send them to us during the webinar, and we’ll be sure to ask our expert.
Moderator: Juan Carlos Serna, Co-Founder & CEO, Right Submission
Presenter: Jeffrey N. Gibbs, Director, Hyman, Phelps & McNamara
Jeffrey N. Gibbs is a Director in the Washington, D.C. law firm of Hyman, Phelps & McNamara, P.C. Before entering private practice, he was an Associate Chief Counsel for Enforcement at the Food and Drug Administration. Jeff also served as a Special Assistant United States Attorney in the District of Columbia in the Civil Division. He is currently Chairman of FDLI’s Board of Directors and was previously FDLI’s General Counsel.
Since entering private practice, Jeff has assisted in vitro diagnostic and medical device companies with a variety of regulatory issues, including FDA product approval, product labeling, clinical studies, promotional and marketing programs, product appeals and enforcement actions. He received FDLI’s Distinguished Service and Leadership Award in 2013, and LMG Life Science’s Star Award in 2016. Jeff previously served on the Human Subjects Review Board of George Mason University, and has written and spoken extensively on a wide variety of FDA regulatory topics.
After registering, you will receive a confirmation email containing information about joining the webinar.
Brought to you by GoToWebinar – Webinars Made Easy®
MassMEDIC has teamed up with DeviceTalks to bring a special discounted rate for DeviceTalks Boston on October 2nd.
For the past six years, DeviceTalks (also a Massachusetts-made product) has brought together leaders from across the spectrum of the medical device industry to discuss the most pressing issues facing the medtech world, while bringing to life some of the stories that help shape this industry and make it so compelling.
We hope you’ll take a look at DeviceTalks’ expanded lineup of speakers, which includes thought leaders from some of New Englands most interesting companies, and an expanded agenda that is packed with important information medtech companies of all sizes need to now.
I hope you’ll join us, along with leaders from Arsenal Medical, Boston Scientific, Corrindus Vascular Robotics, GE Healthcare, Hologic, MC10, NeuroMetrix, NxStage Medical and many more for this full day of programming.
MassMEDIC members save 25% (more than $125) when you use the code “MassMedic” while registering.
October 4, 2017
McDermott Will & Emery
2017 Life Science Dealmaking Symposium
Royal Sonesta, Boston
149 Medical – Acera – Bitome – Canada 3 – Common Sensing – Damae Medical – Devicare – Landsdowne Labs – MedRythms – Myovue, Inc. – Neurallys – NXTSENS – Obsidio Medical – Portabiles GmbH – Prapela – Protembis – Prothia – SensOR Medical – and more…
The MedTech Showcase is an excellent opportunity for members of the region’s medical device community to learn more about the business plans and technologies being developed by local medtech start-ups. This year’s roster of presenting companies includes area companies, and, thanks to MassMEDIC’s partnership with international organizations, the agenda includes start-ups from Canada, the Paris region, Catalunya, and Germany.
In addition to the company presentations, program segments will include a luncheon panel discussion on medtech’s investment outlook and structured networking periods. Once again, this year emerging companies will be judged by the audience on the strength of their technologies, meeting an unmet clinical needs, and the corporate team.
The Showcase attracts over 300 attendees, including industry representatives and potential investors and strategic partners. It’s the region’s largest medtech showcase for medtech start-ups, providing attendees with a preview of new medical technologies and a unique opportunity to interact with medtech entrepreneurs.